Ajay Royan - 12 Jun 2026 Form 4 Insider Report for FRACTYL HEALTH, INC. (GUTS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 18:06:50 UTC
Prior SEC filing
11 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ajay Royan

Key filing fact

Ajay Royan filed Form 4 for FRACTYL HEALTH, INC. (GUTS) on 15 Jun 2026.

Key facts

  • This page summarizes Ajay Royan's Form 4 filing for FRACTYL HEALTH, INC. (GUTS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Jun 2026, 18:06.

Change

  • Previous filing in this sequence was filed on 11 Jun 2026.
  • Current net transaction value: +$19,596.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001875614 Primary reporting owner

Royan Ajay

Relationship
Director
Address
3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON
Signature
/s/ Ajay Royan
Signature date
15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GUTS transaction

Common Stock

Purchase

Transaction value
$19,596
Shares
+23,000
Change %
+128%
Price
$0.8520
Shares after
40,901
Date
12 Jun 2026
Ownership
Direct
Footnotes
F1
GUTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,160,301
Date
12 Jun 2026
Ownership
See Footnote
Footnotes
F2
GUTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,251,900
Date
12 Jun 2026
Ownership
See Footnote
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Open market purchase.

Footnote F2

Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.

Footnote F3

Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .